Skip to main content
. 2012 Nov 7;62(9):1340–1346. doi: 10.1136/gutjnl-2012-302553

Figure 2.

Figure 2

Weekly reduction of median hepatitis C virus (HCV)-RNA levels (log IU/ml) at 1, 2, 4, 8 and 12 weeks between IL28B single nucleotide polymorphisms rs8099917 genotype TT (n=34) and TG/GG (n=20) in HCV genotype 1-infected patients treated with pegylated interferon α plus ribavirin.